Company BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2025-12-12			5-day change	1st Jan Change
45.71 ^CNY	+3.86%		+1.51%	+8.91%

Oct. 23	BGI Genomics Widens Q3 Loss, Revenue Rises 9%	MT
Oct. 23	BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Business description: BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Number of employees: 3,702

Sales by Activity: BGI Genomics Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
Medical Labs & Research	8.4B	6.77B	7.05B	4.35B	3.87B

See all business segments

Geographical breakdown of sales: BGI Genomics Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
Mainland China (Excluding Hong Kong, Macau and Taiwan)	2.8B	2.88B	3.62B	3.46B	3.31B
Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania	3.78B	2.51B	2.79B	558M	246M
Europe and Africa	990M	939M	389M	217M	225M
Americas	833M	432M	245M	116M	90.32M

See all geographic segments

Executive Committee: BGI Genomics Co., Ltd.

Manager	Title	Age	Since
Li Jian Zhao CEO	Chief Executive Officer	49	2021-06-15
Yu Jue Wang DFI	Director of Finance/CFO	47	2021-06-15
Li Ping Ao IRC	Investor Relations Contact	-	-
Qian Xu SEC	Corporate Secretary	41	2015-06-21

See BGI GENOMICS CO., LTD. governance

Composition of the Board of Directors: BGI Genomics Co., Ltd.

Director	Title	Age	Since
Jian Wang CHM	Chairman	71	2015-06-21
Yu Jie Hu BRD	Director/Board Member	41	2015-06-21
Li Jian Zhao BRD	Director/Board Member	49	2021-06-15
Lan Du BRD	Director/Board Member	49	2021-08-12
Si Qi Liu CHM	Chairman	72	2021-06-15
Yu Jue Wang BRD	Director/Board Member	47	2024-06-17
Li Sheng Yu BRD	Director/Board Member	52	2023-07-19

Composition of the Board of Directors

Shareholders: BGI Genomics Co., Ltd.

Name	Equities	%	Valuation
Jian Wang 31.42 %	129,123,184	31.42 %	851 M ¥
Jun Wang 8.389 %	34,470,455	8.389 %	227 M ¥
Hwabao WP Fund Management Co., Ltd. 2.027 %	8,330,442	2.027 %	55 M ¥
E Fund Management Co., Ltd. 1.451 %	5,963,462	1.451 %	39 M ¥
China Merchants Fund Management Co., Ltd. 1.398 %	5,743,126	1.398 %	38 M ¥

Name	Equities	%	Valuation
Jian Wang 63.66 %	1,903,350	63.66 %	13 M ¥

List of BGI GENOMICS CO., LTD. shareholders

Holdings: BGI Genomics Co., Ltd.

Name	Equities	%	Valuation
BANGKOK GENOMICS INNOVATION 37.4%	224,400,000	37.4%	9,409,092 $

Company details: BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd.

8/F, Block B, Huada Space Center

518083, Shenzhen

http://www.bgi.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
BGI GENOMICS CO., LTD.	+3.86%	+1.51%	-3.52%	-22.72%	2.39B
EXACT SCIENCES CORPORATION	+0.14%	+0.44%	+62.37%	+123.42%	19.23B
VERACYTE, INC.	+1.47%	-3.97%	-3.51%	+47.27%	3.34B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	+0.13%	+4.68%	+150.65%	+79.12%	2.35B
CURIOX BIOSYSTEMS CO., LTD	+2.93%	+7.20%	+412.25%	-	1.11B
CAREDX, INC	+3.84%	+10.96%	-12.51%	+62.53%	1.02B
IOVANCE BIOTHERAPEUTICS, INC.	-2.22%	0.00%	-72.36%	-66.72%	893M
SEEGENE, INC.	-0.40%	-2.72%	+7.53%	-9.58%	787M
PROTEINA CO., LTD.	-0.10%	-3.14%	-	-	707M
MARAVAI LIFESCIENCES HOLDINGS, INC.	-2.96%	-2.70%	-36.40%	-72.93%	538M
Average	+0.67%	+2.46%	+56.05%	+17.55%	3.24B
Weighted average by Cap.	+0.63%	+1.02%	+60.02%	+85.77%